Dtsch Med Wochenschr 2009; 134(20): 1060
DOI: 10.1055/s-0029-1222568
Pro & Contra | Commentary
Diabetologie, Endokrinologie
© Georg Thieme Verlag KG Stuttgart · New York

Intensive Blutglukosesenkung zur Reduktion des kardiovaskulären Risikos: pro

Intensive glucose lowering to reduce cardiovascular risk: proS. Martin1
  • 1Westdeutsches Diabetes- und Gesundheitszentrum, Sana Kliniken Düsseldorf GmbH
Further Information

Publication History

Publication Date:
06 May 2009 (online)

Literatur

  • 1 Action to Control Cardiovascular Risk in Diabetes Study Group . Effects of intensive glucose lowering in type 2 diabetes.  N Engl J Med. 2008;  358 2545-2559
  • 2 ADVANCE Collaborative Group . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.  N Engl J Med. 2008;  358 2560-2572
  • 3 Gaede P, Lund-Andersen H, Parving H H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes.  N Engl J Med. 2008;  358 580-591
  • 4 Holman R R, Paul S K, Bethel M A, Matthews D R, Neil H A. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes.  N Engl J Med. 2008;  359 1577-1589
  • 5 Holman R R, Paul S K, Bethel M A, Neil H A, Matthews D R. Long-term follow-up after tight control of blood pressure in type 2 diabetes.  N Engl J Med. 2008;  359 1565-1576
  • 6 UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).  Lancet. 1998;  352 837-853

Prof. Dr. Stephan Martin

Ärztlicher Direktor, Westdeutsches Diabetes- und Gesundheitszentrum, Sana Kliniken Düsseldorf GmbH, Sana Krankenhaus Gerresheim

Gräulinger Str. 120

40625 Düsseldorf

Phone: 0211/2800-3960/-1

Fax: 0211/2800-3962

Email: S.Martin@sana-duesseldorf.de

    >